Article
Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Jan 2000
Junqueira M G, da Silva I D C G, Nogueira-de-Souza N C, Carvalho C V, Leite D B, Gomes M T V, Baracat E C, Lopes L A F, Nicolau S M, Gonçalves W J
Abstract excerpt
The progesterone receptor gene (PROGINS) has been identified as a risk modifier for benign and malignant gynecological diseases. The present case-control study is to evaluate the role of the PROGINS polymorphisms, as risk factor, for endometrial cancer development and to investigate the association between these genetics variants and clinical/pathologic variables of endometrial cancer. PROGINS polymorphism was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
